Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.

× No keyword cloud information.

10 in total

1. PERPHENAZINE: A REAPPRAISAL AFTER EIGHT YEARS.

Authors: F J AYD
Journal: Dis Nerv Syst Date: 1964-05

2. THIORIDAZINE BLOOD LEVELS IN PATIENTS RECEIVING DIFFERENT ORAL FORMS.

Authors: T J MELLINGER; E M MELLINGER; W T SMITH
Journal: Clin Pharmacol Ther Date: 1965 Jul-Aug Impact factor: 6.875

3. Effects of mode of management on plasma chlorpromazine in psychiatric patients.

Authors: L Rivera-Calimlim; L Castañeda; L Lasagna
Journal: Clin Pharmacol Ther Date: 1973 Nov-Dec Impact factor: 6.875

4. Determination of phenothiazine compounds in biologic specimens by UV spectrophotometry.

Authors: J E Wallace; J D Biggs
Journal: J Pharm Sci Date: 1971-09 Impact factor: 3.534

5. Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.

Authors: J E March; D Donato; P Turano; W J Turner
Journal: J Med Date: 1972

6. Determination of perphenazine and fluphenazine in whole blood by gas chromatography.

Authors: N E Larsen; J Naestoft
Journal: Med Lab Technol Date: 1973-04

7. Urinary excretion of perphenazine and its sulfoxide during administration in oral and long-acting injectable form.

Authors: G M van Kempen
Journal: Psychopharmacologia Date: 1971

8. Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector.

Authors: S H Curry
Journal: Anal Chem Date: 1968-07 Impact factor: 6.986

9. Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.

Authors: S H Curry
Journal: Proc R Soc Med Date: 1971-03

10. PERPHENAZINE (TRILAFON) METABOLISM IN PSYCHOTIC PATIENTS.

Authors: C L HUANG; A A KURLAND
Journal: Arch Gen Psychiatry Date: 1964-06

10 in total

7 in total

1. Measurement of plasma levels of tricylic psychoactive drugs and their metabolites by UV reflectance photometry of thin layer chromatograms.

Authors: U Breyer; K Villumsen
Journal: Eur J Clin Pharmacol Date: 1976-03-22 Impact factor: 2.953

Review 2. Plasma level monitoring of antipsychotic drugs.

Authors: T B Cooper
Journal: Clin Pharmacokinet Date: 1978 Jan-Feb Impact factor: 6.447

3. Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline.

Authors: P Kragh-Sorensen; O Borgå; M Garle; L Bolvig Hansen; C E Hansen; E F Hvidberg; N E Larsen; F Sjöqvist
Journal: Eur J Clin Pharmacol Date: 1977-07-19 Impact factor: 2.953

Review 4. Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors: A E Balant-Gorgia; L Balant
Journal: Clin Pharmacokinet Date: 1987-08 Impact factor: 6.447

5. Clinical pharmacokinetic studies of perphenazine.

Authors: C Eggert Hansen; T Rosted Christensen; J Elley; L Bolvig Hansen; P Kragh-Sorensen; N E Larsen; J Naestoft; E F Hvidberg
Journal: Br J Clin Pharmacol Date: 1976-10 Impact factor: 4.335

6. Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs.

Authors: L B Hansen; J Elley; T R Christensen; N E Larsen; J Naestoft; E F Hvidberg
Journal: Br J Clin Pharmacol Date: 1979-01 Impact factor: 4.335

7. Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.

Authors: L B Hansen; N E Larsen
Journal: Psychopharmacology (Berl) Date: 1977-07-18 Impact factor: 4.530

7 in total